Cigna Medical Group Recognized as Center of Excellence
Phoenix - June 20, 2014 -Cigna Medical Group (CMG) has been designated as an "Anticoagulation Center of Excellence" by the Anticoagulation Forum for meeting its standards of providing the highest level of care and achieving quality outcomes for individuals who take blood thinning medications.
CMG has four pharmacist-managed anticoagulation clinics across the Valley at the Phoenix Central, Stapley, Sun City and Superstition Springs health care centers. Antithrombotic medications, also known as blood thinners, are used to help prevent blood clots and ensure smooth blood flow. These medications significantly reduce death from heart attacks and the risk of stroke. Individuals who use them require regular and extensive medical management and monitoring to reduce their risk of excessive bleeding.
"We are so proud to be one of only 39 practices throughout the United States that have achieved this designation," said Heather Jaeger, PharmD CACP, clinical pharmacy manager for CMG. "Receiving this two-year designation is important because it demonstrates our efforts to assure that the 2,500 patients managed by our anticoagulation team each year are receiving the best possible care available."
CMG's dedicated anticoagulation team, made up of pharmacists, registered nurses and medical administrative assistants, monitors individuals who take blood thinning medications. Eighty percent of people cared for at the CMG anticoagulant centers will be on a blood thinner for the rest of their lives, for conditions including atrial fibrillation (irregular heartbeat), mechanical heart valves, stroke and recurrent blood clots in legs and/or lungs.
CMG received the designation after meeting specific standards in five areas of patient care, which include: drug therapy management, disease state management, transition and coordination of care, service operational performance and patient and family education.
About the Anticoagulation Forum
The Anticoagulation Forum is a multidisciplinary non-profit organization that works to improve the quality of care for patients taking antithrombotic medications. The AC Forum promotes the clinical application of evidence-based practices, and provides education and networking opportunities for healthcare professionals. To learn more about the program visit www.excellence.acforum.org.
Cigna Corporation (NYSE: CI) is a global health service company dedicated to helping people improve their health, well-being and sense of security. All products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Connecticut General Life Insurance Company, Cigna Health and Life Insurance Company, Cigna Behavioral Health, Life Insurance Company of North America and Cigna Life Insurance Company of New York. Such products and services include an integrated suite of health services, such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits, and other related products including group life, accident and disability insurance. Cigna maintains sales capability in 30 countries and jurisdictions, and has approximately 80 million customer relationships throughout the world. To learn more about Cigna®, including links to follow us on Facebook or Twitter, visit www.cigna.com.
About Cigna Medical Group
Cigna Medical Group, a division of Cigna HealthCare of Arizona, is one of the Valley's largest multi-specialty group practices with 23 health care centers and two convenience care clinics located throughout metropolitan Phoenix. Most health care centers are equipped with several medical services under one roof, so patients can see their doctor, fill prescriptions and get lab work done. Imaging, vision and hearing services are offered at select locations.
Other articles in News Releases:
- Cigna Waives Customer Cost-Sharing For COVID-19 Treatment And Deploys Clinical Teams To Increase Virtual Care Capacity
- Cigna Makes It Easier For Hospitals To Focus On COVID-19 By Helping Accelerate Patient Transfers
- Cigna Expands Benefits To Support And Protect Its Workforce In Response To COVID-19
- Cigna Corporation Announces Pricing Terms of Tender Offers for up to $1.45 billion in Aggregate Principal Amount of Outstanding Notes
- Cigna Corporation Announces Early Results of Tender Offers for up to $1.45 billion in Aggregate Principal Amount of Outstanding Notes
- Cigna Takes Additional Actions To Protect Customers And Communities Against COVID-19